Full Version
|
Search
The Irish Medicines Board - www.imb.ie
Home
About Us
Consultation
Events
Glossary
Legislation
Links
News
Publications
Recruitment
Register
Safety & Quality
Human Medicines
Veterinary
Medical Devices
Blood, Tissues, Organs
Cosmetics
Patients & Public
Home
»
Human Medicines
»
New EU Pharmacovigilance Legislation
»
EMA and HMA Committee Information
New Legislation Concerning Falsified Medicines
New EU Pharmacovigilance Legislation
About the Legislation
Latest News
Guidance for Marketing Authorisation Holders
Search for Medicines Information
Reporting Suspected Adverse Reactions
Medicines under Additional Monitoring
EMA and HMA Committee Information
HPV School Immunisation
Pandemic (H1N1) 2009
Human Medicines
Clinical Trials
Manufacturing
Laboratory
Wholesale Distribution
Export Certification
Controlled Drugs and Precursor Chemicals
Classification of Medicines
EMA and HMA Committee Information
Following the introduction of the new pharmacovigilance legislation, the European Medicines Agency website will now include the agendas, minutes, recommendations, opinions and decisions of the:
Pharmacovigilance Risk Assessment Committee
(PRAC)
Committee for Medicinal Products for Human Use
(CHMP)
The Heads of Medicines Agency (HMA) will publish similar details for the
Coordination Group for Mutual Recognition and Decentralised Procedures – Human
(CMDh)
Use the links above to access this information.
Latest Information
Provide Feedback